An association of NSAID use and BMI has not been reported, but high dose salicylates can result in lower serum insulin and glucose in diet induced obesity models, which phenocopies the insulin and glucose profile of GKN1−/− mice42. This evidence concerns the gene GKN1 and obesity due to melanocortin 4 receptor deficiency.